即將上市(暗盤交易時段:今日16:15-18:30)
| 公司名稱▼
/
代號▼ | 行業 | 招股價 | 每手股數 | 入場費 | 招股截止日 | 暗盤日期▼ | 上市日期▲ |
| 夢金園 02585.HK | 鐘錶珠寶 | 12-14.4 | 200 | 2,909 | 2024/11/26 |
2024/11/28 | 2024/11/29 |
公司名稱/代號 | 現價2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權益 回報率(%)▼ | 經營 利潤率(%)▼ | 總債項/ 股東權益(%)▼ | 選擇比較 |
杭州九源基因工程股份 02566.HK | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1,334.00% | 1,121.00% | 1,861.00% | |
微創機器人-B 02252.HK | 9.200 | +5.505% | -3.16% | 89.38億 | N/A | 15.40 | N/A | -19,484.00% | -93,232.00% | 11,462.00% | |
昊海生物科技 06826.HK | 28.000 | +3.321% | -7.59% | 65.01億 | 14.58 | 1.08 | 40.836% | 736.00% | 1,955.00% | 722.00% | |
諾輝健康 06606.HK | 14.140 | 0.000% | 0.00% | 64.73億 | N/A | 2.56 | N/A | -373.00% | -945.00% | 1,155.00% | |
歸創通橋-B 02190.HK | 11.240 | +1.079% | +2.00% | 36.79億 | N/A | 1.11 | N/A | -258.00% | -1,468.00% | 183.00% | |
沛嘉醫療-B 09996.HK | 3.740 | -0.796% | -4.59% | 25.00億 | N/A | 1.01 | N/A | -1,726.00% | -8,865.00% | 972.00% | |
先瑞達醫療-B 06669.HK | 6.890 | -0.863% | -9.22% | 21.59億 | 130.00 | 1.51 | N/A | 112.00% | 528.00% | 1,805.00% | |
微泰醫療-B 02235.HK | 4.550 | +1.111% | +0.22% | 19.11億 | N/A | 0.85 | N/A | -607.00% | -4,918.00% | 1.00% | |
心通醫療-B 02160.HK | 0.720 | +4.348% | +2.86% | 17.37億 | N/A | 0.68 | N/A | -2,020.00% | -11,748.00% | 302.00% | |
康灃生物-B 06922.HK | 6.920 | -0.288% | +1.32% | 16.55億 | N/A | 9.30 | N/A | -6,038.00% | -25,664.00% | 682.00% | |
健世科技-B 09877.HK | 3.130 | -2.795% | +13.00% | 13.06億 | N/A | 0.96 | N/A | -3,015.00% | N/A | 357.00% | |
鷹瞳科技-B 02251.HK | 11.640 | +0.692% | +1.22% | 12.06億 | N/A | 0.71 | N/A | -860.00% | -7,124.00% | 61.00% | |
心瑋醫療-B 06609.HK | 24.000 | +7.623% | +17.36% | 9.32億 | N/A | 0.79 | N/A | -874.00% | -4,337.00% | 338.00% | |
百心安-B 02185.HK | 1.580 | +0.637% | -14.59% | 3.85億 | N/A | 0.47 | N/A | -2,350.00% | N/A | 24.00% | |
(坤)博醫療-B 02216.HK | 0.490 | +6.522% | +4.26% | 2.58億 | N/A | 0.18 | N/A | -1,515.00% | -27,310.00% | 127.00% | |
潤邁德-B 02297.HK | 0.160 | -1.840% | +3.23% | 1.87億 | N/A | 0.33 | N/A | -2,249.00% | -15,813.00% | 388.00% | |
|